Author:
Kean Walter F.,Kean Robert,Buchanan W. Watson
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,Immunology
Reference63 articles.
1. Appelrouth, D. J., Chodock, A. L., Miller, J. L. and Powell, W. R. (1986). A comparison of single daily doses of oxaprozin with multiple daily doses of ibuprofen for the treatment of Rheumatoid Arthritis, Seminars in Arthritis and Rheumatism 15 (Suppl. 2), 54–58.
2. Barber, J. V., Collins, R. L., Kitridou, R. C., Lehman, D. H., Wenger, M. E. and Wold, R. T. (1986). The efficacy and safety of single daily doses of oxaproxin in the treatment of Rheumatoid Arthritis: a comparison with aspirin, Seminars in Arthritis and Rheumatism 15 (3), Suppl. 2, 47–53.
3. Bevilacqua, M. (2002). Effects of oxaprozin and of other 2-arylpropionic acid derivatives on Nuclear Factor κB (NF-κB) activation, Inflammopharmacology 10, 173–183.
4. Blau, R. A., Boyles, P. W., Brame, C. L., Bress, N. M., Clarke, J. P., Conner, S. K., Cummings, N., Krauster, R. E., Poiley, J. E., Roth, S. H. and Spindler, J. S. (1983). Comparison of the efficacy and safety of oxaprozin (600 mg b.i.d.) versus ibuprofen (300 mg q.i.d.) in the treatment of patients with active Rheumatoid Arthritis, Internal report (Ref: Protocol B).
5. Bombardier, C., Laine, L., Reicin, A., Shapiro, D., Burgos, Vargas, R., Davis, B., Day, R., Fer-raz, M. B., Hawkey, C. J., Hochberg, M. C., Kvien, T. K. and Schnitzer, T. J. (2000). Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis, N. Engl. J. Med. 343, 1520–1528.
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献